Improvements in Glycemic Control Achieved by Altering the tmax Setting in the iLet® Bionic Pancreas When Using Fast-Acting Insulin Aspart: A Randomized Trial
mediaposted on 14.06.2021, 07:42 by Adis journals on behalf of, Steven J. Russell, Courtney Balliro, Magnus Ekelund, Firas El-Khatib, Tina Graungaard, Evelyn Greaux, Mallory Hillard, Rabab Z. Jafri, Nathan Rathor, Raj Selagamsetty, Jordan Sherwood, Edward R. Damiano
Article full text
The above summary slide and plain language summary represent the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.